Stocktoria
Arcus Biosciences, Inc. RCUS
NYSE · stock · Pharmaceutical Preparations · website · IPO 2018-03-15
Arcus Biosciences, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,763,113 | $148.7M | 7.79% |
| CITADEL ADVISORS LLC | 3,162,257 | $97.5M | 2.52% |
| TWO SIGMA INVESTMENTS, LP | 635,404 | $19.6M | 0.51% |
| MILLENNIUM MANAGEMENT LLC | 133,110 | $4.1M | 0.11% |
| D. E. Shaw & Co., Inc. | 96,417 | $3.0M | 0.08% |
| AQR CAPITAL MANAGEMENT LLC | 83,861 | $2.6M | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.